Dudediligence.

Alector, Inc

ALECNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$15.3MSep ’24$54.2MDec ’24$3.7MMar ’25$7.9MJun ’25$3.3MSep ’25$6.2MDec ’25$1.0MMar ’26$3.3MJun ’26
Net income, by quarter
−$42.2MSep ’24−$2.1MDec ’24−$40.5MMar ’25−$30.5MJun ’25−$34.7MSep ’25−$37.3MDec ’25−$22.9MMar ’26−$23.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$207.1M$133.6M$97.1M$100.6M$21.0M
Operating income−$37.4M−$137.8M−$151.7M−$145.0M−$156.0M
Net income−$36.3M−$133.3M−$130.4M−$119.0M−$143.0M
Operating cash flow$298.6M−$20.3M−$184.2M−$229.9M−$184.0M
Free cash flow$295.3M−$24.4M−$186.5M−$231.2M−$184.1M
Cash$329.2M$154.3M$74.6M$33.0M$65.8M
Debtnone on filenone on file$0.00$9.4M$9.7M
Shares outstanding82.0M82.9M84.9M99.1M110.4M